Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Depreciation & Amortization (CF): 2013-2024

Historic Depreciation & Amortization (CF) for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to $100,000.

  • vTv Therapeutics' Depreciation & Amortization (CF) fell 90.91% to $2,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $47,000, marking a year-over-year decrease of 53.00%. This contributed to the annual value of $100,000 for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, vTv Therapeutics' Depreciation & Amortization (CF) is $100,000, which was down 0.00% from $100,000 recorded in FY2023.
  • In the past 5 years, vTv Therapeutics' Depreciation & Amortization (CF) ranged from a high of $100,000 in FY2020 and a low of $100,000 during FY2020.
  • Over the past 3 years, vTv Therapeutics' median Depreciation & Amortization (CF) value was $100,000 (recorded in 2024), while the average stood at $100,000.
  • Data for vTv Therapeutics' Depreciation & Amortization (CF) shows a peak YoY soared of 156.41% (in 2020) over the last 5 years.
  • vTv Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $100,000 in 2020, then remained steady at $100,000 in 2021, then remained steady at $100,000 in 2022, then remained steady at $100,000 in 2023, then remained steady at $100,000 in 2024.